Research guide
LY3298176Tirzepatide research guide
Plain-language notes on LY3298176 identity, GIPR and GLP-1R receptor literature, cited study records, and lab-only handling boundaries.
01 - Short version
The quick read.
Plain-language context only. No preparation steps, no use instructions, and no product-effect claims.
New to Tirzepatide? Here's the short version. Tirzepatide is the common name used for LY3298176, a modified peptide described in literature across GIPR and GLP-1R receptor systems.
This guide keeps study context separate from Form Laboratories product claims. It does not provide preparation, administration, or applied-use directions.
Lot identity, purity, appearance, and release status remain COA-led. Published papers are used only as scientific background.
02 - What it is
The plain identity details.
- Compound
- Tirzepatide
- Research code
- LY3298176
- CAS
- 2023788-19-2
- Molecular formula
- C225H348N48O68
- Molecular weight
- 4813.5 Da
- Structure note
- Modified 39-amino-acid lipidated peptide
- Format
- Lyophilized research reference
- Storage
- 2-8 C, protect from light
- Lot
- TIRZ-2506
Identity information lets you compare the guide with the product label. It is not a certificate, mixing method, or instruction for use.
03 - What studies look at
The main research themes.
Each note stays at study-context level and avoids use instructions.
01Dual incretin discovery recordCoskun et al., Molecular Metabolism, 2018.
The paper identifies LY3298176 through GIP and GLP-1 receptor research systems.
02Biased-signalling paperWillard et al., JCI Insight, 2020.
The paper supports careful receptor-bias language without creating applied-use claims.
03Comparator controlled-study recordFrias et al., New England Journal of Medicine, 2021.
The guide lists this as literature chronology only.
Storage, appearance, purity, and release state come from the matching lot record.
Use the product label and matching COA as the authority for storage, appearance, purity, and release state.
This guide is educational context only. It does not include preparation, administration, human-use, or veterinary-use directions.
For laboratory research use only. 18+ only. Not for human consumption or veterinary use.
05 - FAQ
Common questions.
What is TIRZ supplied for?
TIRZ is supplied as laboratory research material only. It is 18+ only, not for human consumption, and not for veterinary use.
Does this page include matching COA information?
Yes. The product page lists lot, identity, purity, appearance, release status, and storage notes for TIRZ.
How should the vial be handled after delivery?
Follow the label and matching COA paperwork. This page repeats 2-8 C storage guidance and light-protection notes before checkout.
What is Tirzepatide?
Tirzepatide is a lab-made peptide, known in studies as LY3298176, with published work across GIPR and GLP-1R receptor systems.
Why are two receptor names listed?
GIPR and GLP-1R are the receptor arms named in the papers. They identify the research area; they are not directions for human use.
Can this be used outside a lab?
No. Tirzepatide from Form Laboratories is for laboratory research only, 18+ only, and not for human consumption.
06 - References
A few key references.
Check publisher identifiers against the source before formal citation.
Frias JP et al. New England Journal of Medicine. 2021;385(6):503-515.
10.1056/NEJMoa2107519Citations compiled 2026-07 from publisher records. This bibliography is not lab-use guidance.
Related
